 |
- MR LATVIA: Development of Magnetic Resonance in Latvia (2024 -2027)
- WIDEnzymes: Widening Synergies for Novel Enzymes Development (2024 – 2027)
- A4L_BRIDGE: Alliance4Life Bridging the Research and Innovation Gap in Life Sciences (2024 – 2028)
- AVITHRAPID: Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases (2024 -2028)
- Phototheraport: Luminescent Implants as Ports for Light-Based Therapies (2024 – 2026)
- TransPharm: Towards a more sustainable European pharmaceutical production of APIs (2022-2026)
- Fragment-Screen: From fragments to high affinity binders interfacing integrated structural biology, medicinal chemistry and artificial intelligence (2023-2026)
- NATALION: Natural Products Research at Latvian Institute of Organic Synthesis as a driver for Excellence in Innovation (2023-2027)
- Remote NMR (R-NMR): Moving NMR infrastructures to remote access capabilities (2022-2025)
- ISIDORe: Integrated Services for Infectious Disease Outbreak Research (2022 -2025)
- RM ROADMAP: Creating Framework Conditions for Research Management to Strengthen the European Research Area (2022-2025)
 |
- RISK-HUNT3R: Risk assessment of chemicals integrating human centric next generation testing strategies promoting the 3Rs (2021-2026)
- ALISE: Antibody Light-Induced Selectivity Enhancement (2021-2025)
- BBCE: Baltic Biomaterials Centre of Excellence (2020-2026)
- ERA4TB: European Regimen Accelerator for Tuberculosis (2020-2025)
 |
Estonia–Latvia programme 2021–2027 implemented under the European territorial cooperation goal (Interreg)
- EstLat Alliance in Drug Development – PharmaBoost (2023 -2025)
 |
Fundamental and Applied Research Projects (Latvian Research Council)
- Project No. lzp-2024/1-0382 Novel metabolic therapy for the complication management of inherited fatty acid oxidation disorders (2025-2027)
- Project No. lzp-2024/1-0364 Exploring the Behavior of Self-assembling Styrylpyridinium and Its Aza-Analog Fluorescent Probes within Liposomes as Mimics of Biological Membranes (LipAgrStyrPro) (2025-2027)
- Project No. lzp-2024/1-0309 Novel source towards challenging monofluorocarbene (2025-2027)
- Project No. lzp-2024/1-0330 Next-generation fluorescent probes for the detection of protein unfolding (2025-2027)
- Project No. lzp-2023/1-0312: Characterisation of fungal cell wall architecture using solid-state nuclear magnetic resonance spectroscopy at fast spinning regime (2024-2026)
- Project No. lzp-2023/1-0287: HMGCR enzyme deficiency-induced alterations in cellular energy metabolism pathways (2024-2026)
- Project No. lzp-2023/1-0312: Characterisation of fungal cell wall architecture using solid-state nuclear magnetic resonance spectroscopy at fast spinning regime (2024-2026)
- Project No. lzp-2023/1-0288 Metabolic therapy for the treatment of heart failure with preserved ejection fraction (2023 – 2025)
- Project No. lzp-2022/1-0335 F-Nodal Synthesis: Exploring Potential of Monofluorinated One Carbon Synthons (2023-2026)
- Project No. LZP-2021/1-0595: Electrochemical synthesis of chelation-stabilized organo-λ3-bromanes (2022-2024)
- Project No. LZP-2021/1-0593: Bioinert Brush-Polymers as Theranostics for Metastatic Breast Cancer Therapy (2022-2024)
- Project No. LZP-2021/1-0578: Synthetic approach to sulfur-based enantiopure gamma-lactam bioisosteres (2022-2024)
- Project No. LZP-2021/1-0563: Sigma-1 Receptor: a new player of pathogenesis and therapy in cardiometabolic diseases? (2022-2024)
| ERA-NET Projects |
- MURYXIN: The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin (2023-2026)
- (2023-2025)
 |
- SIGMA-1EUROPE: European Network for Sigma-1 Receptor as a Therapeutic Opportunity (2024 – 2028)
- EU-METAHEART: EUropean network to tackle METAbolic alterations in HEART failure (2023 – 2027)
- ML4NGP Non-globular proteins in the era of Machine Learning (2022 – 2026)
- COZYME: Pan-European Network on Computational Redesign of Enzymes (2022-2026)
- OneHealthdrugs: One Health drugs against parasitic vector borne diseases in Europe and beyond (2022-2026)
- EURESTOP: European Network for diagnosis and treatment of antibiotic-resistant bacterial infections (2022-2026)
- IMMUNO-model: Modelling immunotherapy response and toxicity in cancer (2022-2026)
- ANDRONET: European andrology network– research coordination, education and public awareness (2021-2025)
- TEATIME: Improving biomedical research by automated behaviour monitoring in the animal home-cage (2021-2025)
- VOICES: Making Early Career Investigators’ Voices Heard for Gender Equality (2021-2025)
- Mye-InfoBank: Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer (2021-2025)
- VascAgeNet: Network for Research in Vascular Ageing (2019 – 2024)
| Mutual fund Taiwan–Latvia–Lithuania |
- SYNERGISM: Synthesis and characterization of new organic emitters exibiting long-lived emissions for brain imaging (2024-2026)
- Structure determination of transthyretin amyloid fibris (2024 – 2026)
- Exploring Early Events in the Cold Denatured Apoptotic Bid Protein Using Sensitivity-Enhanced EPR and NMR (2023 – 2024)
- Synthesis and study of deep-blue TTF fluorescent emitters to exceed theoretical OLED external quantum efficiency reaching 15% (2023 – 2024)
| The Recovery and Resilience Facility |